HM

Heinz Maeusli

Director at Inventiva Pharma

Heinz Maeusli has been a member of the Board of Directors since 2019. Before joining the Board of Directors, Mr. Maeusli was Chief Financial Officer of Advanced Accelerator Applications (AAA) from 2003 to 2018, where he was instrumental in making this company a leader in the sector of nuclear medicine. In this capacity, he led AAA’s IPO on the Nasdaq in November 2015 and was involved in the sale of AAA to Novartis in January 2018. Throughout his career, he has developed an expertise in operational, organizational, financial and cultural aspects relating to the growth and integration of international companies.

Heinz Maeusli holds an MBA from Columbia University, New York, USA and a MA in Business from the University of St. Gallen in Switzerland.

Timeline

  • Director

    Current role